Repligen Corp.

History

Year	Detail
1981	Repligen, a biopharmaceutical company focused on developing consumable products for manufacturing biological drugs, was founded in 1981 by two distinguished scientists, Alexander Rich, and Paul Schimmel, who pioneered breakthrough advances in science and technology.
2015	Repligen acquired TangenX Technology Corp. of Shrewsbury, Massachusetts, the maker of the innovative single-use Sius line of tangential flow filtration cassettes and hardware used in downstream biopharmaceutical manufacturing processes for $40 million to strengthen the company's capability in filtration market.
2017	The company acquired Spectrum Inc., a bioprocess filtration specialist, for approximately $359 million to expand its commercial footprint in the market.
2020	The company acquired Artesyn Biosolutions, an Irish biotech company, for $200 million to add single-use downstream bioprocessing systems to the portfolio.
2023	The company acquired FlexBiosys Inc., a designer and manufacturer of single-use bioprocessing bags and assemblies, for $41 million to provide a complete single-use fluid management portfolio of products for the company's biopharmaceutical manufacturing customers.
2023	Repligen acquired Metenova, a privately held Swedish company that specializes in the manufacturing of magnetic mixers for pharmaceutical and biotechnology applications, to expand its Fluid Management portfolio.